Patient-specific protein aggregates in myofibrillar myopathies: Laser microdissection and differential proteomics for identification of plaque components

Proteomics

Volumn 12, Issue 23-24, 2012, Pages 3598-3609

  Feldkirchner, Sarah ^a   Schessl, Joachim ^a   Müller, Stefan ^b   Schoser, Benedikt ^a   Hanisch, Franz Georg ^b  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b UNIVERSITY OF COLOGNE   (Germany)

Author keywords

Biomedicine; Myofibrillar myopathy; Plaques; Protein aggregates

Indexed keywords

ALPHA ACTIN; ALPHA CRYSTALLIN; ALPHA TUBULIN; DESMIN; FILAMIN A; NEBULIN; PDZ PROTEIN; PROTEIN S 100;

AMINO ACID SEQUENCE; ARTICLE; CONTROLLED STUDY; GENE MUTATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LASER MICRODISSECTION; LIMIT OF QUANTITATION; LIQUID CHROMATOGRAPHY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MUSCLE ATROPHY; MUSCLE BIOPSY; MYOFIBRILLAR MYOPATHY; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN ANALYSIS; PROTEOMICS; SKELETAL MUSCLE; TANDEM MASS SPECTROMETRY;

HUMANS; LASER CAPTURE MICRODISSECTION; MUSCLE, SKELETAL; MUSCULAR DISEASES; MUTATION; PROTEOME; PROTEOMICS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; STAINING AND LABELING;

EID: 84871346337     PISSN: 16159853     EISSN: 16159861     Source Type: Journal    
DOI: 10.1002/pmic.201100559     Document Type: Article

References (33)

1. Selcen, D., Myofibrillar myopathies. Neuromuscul. Disord. 2011, 21, 161-171.
2. Selcen, D., Myofibrillar myopathies. Curr. Opin. Neurol. 2010, 23, 477-481.
3. Bar, H., Schopferer, M., Sharma, S., Hochstein, B. et al., Mutations in desmin's carboxy-terminal "tail" domain severely modify filament and network mechanics. J. Mol. Biol. 2010, 397, 1188-1198.
4. Goldfarb, L. G., Park, K. Y., Cervenakova, L., Gorokhova, S. et al., Missense mutations in desmin associated with familial cardiac and skeletal myopathy. Nat. Genet. 1998, 19, 402-403.
5. Pinol-Ripoll, G., Shatunov, A., Cabello, A., Larrode, P. et al., Severe infantile-onset cardiomyopathy associated with a homozygous deletion in desmin. Neuromuscul. Disord. 2009, 19, 418-422.
6. Berciano, J., Gallardo, E., Dominguez-Perles, R., Garcia, A. et al., Autosomal-dominant distal myopathy with a myotilin S55F mutation: sorting out the phenotype. J. Neurol. Neurosurg. Psychiatry 2008, 79, 205-208.
7. Foroud, T., Pankratz, N., Batchman, A. P., Pauciulo, M. W. et al., A mutation in myotilin causes spheroid body myopathy. Neurology 2005, 65, 1936-1940.
8. Olive, M., Goldfarb, L. G., Shatunov, A., Fischer, D. et al., Myotilinopathy: refining the clinical and myopathological phenotype. Brain 2005, 128, 2315-2326.
9. Penisson-Besnier, I., Talvinen, K., Dumez, C., Vihola, A. et al., Myotilinopathy in a family with late onset myopathy. Neuromuscul. Disord. 2006, 16, 427-431.
10. Selcen, D., Engel, A. G., Mutations in myotilin cause myofibrillar myopathy. Neurology 2004, 62, 1363-1371.
11. Griggs, R., Vihola, A., Hackman, P., Talvinen, K. et al., Zaspopathy in a large classic late-onset distal myopathy family. Brain 2007, 130, 1477-1484.
12. Selcen, D., Engel, A. G., Mutations in ZASP define a novel form of muscular dystrophy in humans. Ann. Neurol. 2005, 57, 269-276.
13. Reilich, P., Schoser, B., Schramm, N., Krause, S. et al., The p.G154S mutation of the alpha-B crystallin gene (CRYAB) causes late-onset distal myopathy. Neuromuscul. Disord. 2010, 20, 255-259.
14. Selcen, D., Engel, A. G., Myofibrillar myopathy caused by novel dominant negative alpha B-crystallin mutations. Ann. Neurol. 2003, 54, 804-810.
15. Kley, R. A., Hellenbroich, Y., van der Ven, P. F., Furst, D. O. et al., Clinical and morphological phenotype of the filamin myopathy: a study of 31 German patients. Brain 2007, 130, 3250-3264.
16. Luan, X., Hong, D., Zhang, W., Wang, Z. et al., A novel heterozygous deletion-insertion mutation (2695-2712 del/GTTTGT ins) in exon 18 of the filamin C gene causes filaminopathy in a large Chinese family. Neuromuscul. Disord. 2010, 20, 390-396.
17. Shatunov, A., Olive, M., Odgerel, Z., Stadelmann-Nessler, C. et al., In-frame deletion in the seventh immunoglobulin-like repeat of filamin C in a family with myofibrillar myopathy. Eur. J. Hum. Genet. 2009, 17, 656-663.
18. Vorgerd, M., van der Ven, P. F., Bruchertseifer, V., Lowe, T. et al., A mutation in the dimerization domain of filamin c causes a novel type of autosomal dominant myofibrillar myopathy. Am. J. Hum. Genet. 2005, 77, 297-304.
19. Selcen, D., Muntoni, F., Burton, B. K., Pegoraro, E. et al., Mutation in BAG3 causes severe dominant childhood muscular dystrophy. Ann. Neurol. 2009, 65, 83-89.
20. Knoblauch, H., Geier, C., Adams, S., Budde, B. et al., Contractures and hypertrophic cardiomyopathy in a novel FHL1 mutation. Ann. Neurol. 2010, 67, 136-140.
21. Quinzii, C. M., Vu, T. H., Min, K. C., Tanji, K. et al., X-linked dominant scapuloperoneal myopathy is due to a mutation in the gene encoding four-and-a-half-LIM protein 1. Am. J. Hum. Genet. 2008, 82, 208-213.
22. Schessl, J., Taratuto, A. L., Sewry, C., Battini, R. et al., Clinical, histological and genetic characterization of reducing body myopathy caused by mutations in FHL1. Brain 2009, 132, 452-464.
23. Schessl, J., Zou, Y., McGrath, M. J., Cowling, B. S. et al., Proteomic identification of FHL1 as the protein mutated in human reducing body myopathy. J. Clin. Invest. 2008, 118, 904-912.
24. Schoser, B., Goebel, H. H., Janisch, I., Quasthoff, S. et al., Consequences of mutations within the C terminus of the FHL1 gene. Neurology 2009, 73, 543-551.
25. Shalaby, S., Hayashi, Y. K., Goto, K., Ogawa, M. et al., Rigid spine syndrome caused by a novel mutation in four-and-a-half LIM domain 1 gene (FHL1). Neuromuscul. Disord. 2008, 18, 959-961.
26. Windpassinger, C., Schoser, B., Straub, V., Hochmeister, S. et al., An X-linked myopathy with postural muscle atrophy and generalized hypertrophy, termed XMPMA, is caused by mutations in FHL1. Am. J. Hum. Genet. 2008, 82, 88-99.
27. Claeys, K. G., Sozanska, M., Martin, J. J., Lacene, E. et al., DNAJB2 expression in normal and diseased human and mouse skeletal muscle. Am. J. Pathol. 2010, 176, 2901-2910.
28. Olive, M., Janue, A., Moreno, D., Gamez, J. et al., TAR DNA-Binding protein 43 accumulation in protein aggregate myopathies. J. Neuropathol. Exp. Neurol. 2009, 68, 262-273.
29. Selcen, D., Ohno, K., Engel, A. G., Myofibrillar myopathy: clinical, morphological and genetic studies in 63 patients. Brain 2004, 127, 439-451.
30. Espina, V., Wulfkuhle, J. D., Calvert, V. S., VanMeter, A. et al., Laser-capture microdissection. Nat. Protoc. 2006, 1, 586-603.
31. Albert, T. K., Laubinger, W., Müller, S., Hanisch, F. G. et al., Human intestinal TFF3 forms disulfide-linked heteromers with the mucus-associated FCGBP protein and is released by hydrogen sulfide. J. Proteome Res. 2010, 9, 3108-3117
32. Wisniewski, J.R., Zougman, A., Nagaraj, N., Mann, M. Universal sample preparation method for proteome analysis. Nat. Methods 2009, 6(5), 359-362
33. Thiele, H., Glandorf, J., Hufnagel, P., Körting, G. et al., Managing proteomics data: from generation and data warehousing to central data repository. J. Proteomics Bioinform. 2008, 1(9), 485-450